Results 121 to 130 of about 6,944 (246)

Prevalence of Therapeutic Inertia in the Management of Overweight and Obesity in Patients With a Diagnosis of Type 2 Diabetes Who Are Followed up by Primary Care Physicians

Obesity Science &Practice, Volume 12, Issue 2, April 2026.
ABSTRACT Introduction Information on therapeutic inertia (TI) in weight loss in people with type 2 diabetes (T2D) is limited. Objective To describe the prevalence of TI in the management of overweight/obesity in people with T2D undergoing primary care program (PCP) follow‐up and weight changes according to the prescribed treatment.
Pablo Aschner, Diana Henao‐Carrillo
wiley   +1 more source

Weight loss mediates improvement in proinsulin processing during GLP-1 receptor agonist treatment

Diabetology & Metabolic Syndrome
Aims To observe the effect of glucagon-like peptide-1 receptor agonists (GLP-1RA) combined with metformin and metformin monotherapy on proinsulin changes in patients with obesity following weight loss.
Renjiao Liu, Dangmin Hou, Mingxin Leng, Zhouhuiling Li, Yifang Zhang, Lingling Liu, Xincheng Wang, Chunjun Li   +7 more
doaj   +1 more source

GLP‐1RAs and cardiovascular risk reduction in psoriasis: A retrospective cohort study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Elaine J. Ma, Alyssa M. Roberts, Charlotte Y. Jeong, Peichi Chou, Abigail Katz, Yvonne Nong, Nicole Johnsen, Matthew Yan, Maria T. Ochoa, April W. Armstrong   +9 more
wiley   +1 more source

GLP‐1 Receptor Agonists Versus Bariatric Surgery: Effects of Weight Loss and BMI on Subsequent General Surgical Procedures

Clinical Obesity, Volume 16, Issue 2, April 2026.
ABSTRACT Obesity and T2DM substantially increase postoperative risk, with higher surgical site infections in obesity and up to a 65% increase in overall complications in T2DM. This study assesses the impact of weight loss interventions—metabolic bariatric surgery (MBS) and glucagon‐like peptide‐1 receptor agonists (GLP‐1RA)—on BMI reduction and how ...
Shahzaib Zindani, Selamawit Woldesenbet, Abdullah Altaf, Mujtaba Khalil, Zayed Rashid, Jun Kawashima, Areesh Mevawalla, Azza Sarfraz, Sabrena Noria, Bradley Needleman, Timothy M. Pawlik   +10 more
wiley   +1 more source

#1700 Heterogeneity in characteristics of target population and definitions of renal outcome on evaluating the renoprotective effect of GLP-1RA in patients with diabetes: a systematic review and meta-analysis of observational studies versus randomized controlled trials [PDF]

Xiaoyu Wu, Zhaohui Bai, Yue Zhang, Dongze Ji, Na He, Yang Xu   +5 more
openalex   +1 more source

Trends in First-Line Glucose-Lowering Drug Use in Adults With Type 2 Diabetes in Light of Emerging Evidence for SGLT-2i and GLP-1RA

, 2021
Ho‐Jin Shin, Sebastian Schneeweiß, Robert J. Glynn, Elisabetta Patorno   +3 more
openalex   +1 more source

Exploratory Analysis of Liraglutide Effects on Obstructive Sleep Apnea and Health‐Related Quality of Life in Individuals With Obesity and COPD: A Secondary Analysis of a Randomised Controlled Trial

Clinical Obesity, Volume 16, Issue 2, April 2026.
ABSTRACT Obstructive sleep apnea (OSA) is associated with chronic obstructive pulmonary disease (COPD) and obesity, and all three are linked to reduced health‐related quality of life (HRQoL). Coexistence of OSA and COPD increases morbidity and mortality compared to each condition alone.
Sofie Krogh Wolsing, Ayse Dudu Altintas Dogan, Claus Bogh Juhl, Søren Hess, Torben Tranborg Jensen, Else‐Marie Bladbjerg, Ole Hilberg   +6 more
wiley   +1 more source

Genetic variability in sodium-glucose cotransporter 2 and glucagon-like peptide 1 receptor effect on glycemic and pressure control in type 2 diabetes patients treated with SGLT2 inhibitors and GLP-1RA in the everyday clinical practice [PDF]

Gašper Tonin, Katja Goričar, Tanja Blagus, Andrej Janež, Vita Dolžan, Jasna Klen   +5 more
openalex   +1 more source

Efficacy of Modern Diabetes Treatments- Dpp-4i, Sglt-2i, Glp-1ra- in White and Asian Patients With Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

, 2020
Sushrima Gan, Adem Y. Dawed, Louise A. Donnelly, ATN Nair, Colin NA Palmer, Viswanathan Mohan, Ewan R. Pearson   +6 more
openalex   +1 more source

Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare Population [PDF]

, 2017
Hiep Nguyen, Robert Dufour, Amanda Caldwell-Tarr   +2 more
openalex   +1 more source